Robert M. Burk

1.4k total citations
31 papers, 883 citations indexed

About

Robert M. Burk is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Robert M. Burk has authored 31 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 11 papers in Organic Chemistry and 10 papers in Molecular Biology. Recurrent topics in Robert M. Burk's work include Inflammatory mediators and NSAID effects (8 papers), Glaucoma and retinal disorders (7 papers) and Chemical synthesis and alkaloids (4 papers). Robert M. Burk is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Glaucoma and retinal disorders (7 papers) and Chemical synthesis and alkaloids (4 papers). Robert M. Burk collaborates with scholars based in United States, Ireland and United Kingdom. Robert M. Burk's co-authors include Michael B. Roof, Larry E. Overman, David F. Woodward, Achim H.‐P. Krauss, Charles E. Protzman, Diane D‐S. Tang‐Liu, Karen M. Kedzie, Yuanbo Liang, Andrew Acheampong and Allan Weber and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Lipid Research.

In The Last Decade

Robert M. Burk

31 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert M. Burk United States 15 328 275 245 148 95 31 883
Michael E. Garst United States 21 188 0.6× 798 2.9× 394 1.6× 215 1.5× 46 0.5× 75 1.5k
Takashi Ochiai Japan 24 299 0.9× 416 1.5× 785 3.2× 24 0.2× 65 0.7× 80 1.9k
Gideon Shapiro United States 19 137 0.4× 345 1.3× 590 2.4× 32 0.2× 10 0.1× 51 1.2k
Alan D. Robertson United Kingdom 17 173 0.5× 205 0.7× 405 1.7× 10 0.1× 57 0.6× 31 887
Pei Xu China 26 19 0.1× 632 2.3× 437 1.8× 84 0.6× 14 0.1× 80 1.6k
Andrea Aramini Italy 20 46 0.1× 285 1.0× 221 0.9× 18 0.1× 20 0.2× 64 927
Davide Colavito Italy 16 114 0.3× 154 0.6× 201 0.8× 33 0.2× 56 0.6× 43 830
Larry P. Bausher United States 11 31 0.1× 141 0.5× 211 0.9× 137 0.9× 8 0.1× 21 515
Henri Cousse France 12 130 0.4× 349 1.3× 217 0.9× 3 0.0× 48 0.5× 40 906
John L. Sawyer United States 16 57 0.2× 186 0.7× 230 0.9× 33 0.2× 21 0.2× 36 650

Countries citing papers authored by Robert M. Burk

Since Specialization
Citations

This map shows the geographic impact of Robert M. Burk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Burk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Burk more than expected).

Fields of papers citing papers by Robert M. Burk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Burk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Burk. The network helps show where Robert M. Burk may publish in the future.

Co-authorship network of co-authors of Robert M. Burk

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Burk. A scholar is included among the top collaborators of Robert M. Burk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Burk. Robert M. Burk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burk, Robert M. & David F. Woodward. (2007). A historical perspective and recent advances in prostamide research and therapeutics.. PubMed. 10(4). 413–21. 11 indexed citations
2.
Kharlamb, A., et al.. (2006). Ciliary Muscle Relaxation Does Not Explain the Profound Ocular Hypotension Produced by a Selective Prostanoid EP4 Receptor Agonist 3,7–Dithia PGE1 in Monkeys. Investigative Ophthalmology & Visual Science. 47(13). 413–413. 2 indexed citations
3.
Woodward, David F., Achim H.‐P. Krauss, Charles E. Protzman, et al.. (2006). Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin‐ethanolamides) in the feline iris. British Journal of Pharmacology. 150(3). 342–352. 51 indexed citations
4.
Kharlamb, A., Achim H.‐P. Krauss, David F. Woodward, et al.. (2004). PROSTANOID EP4 RECEPTOR STIMULATION PRODUCES PROFOUND OCULAR HYPOTENSION THAT INVOLVES PRESSURE DEPENDENT OUTFLOW. Investigative Ophthalmology & Visual Science. 45(13). 1035–1035. 3 indexed citations
5.
Weber, Allan, Jinsong Ni, Andrew Acheampong, et al.. (2004). Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry. Journal of Lipid Research. 45(4). 757–763. 101 indexed citations
6.
Matias, Isabel, Luciano De Petrocellis, Tiziana Bisogno, et al.. (2004). Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism. Journal of Pharmacology and Experimental Therapeutics. 309(2). 745–757. 116 indexed citations
7.
Woodward, David F., Achim H.‐P. Krauss, Yuanbo Liang, et al.. (2003). Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024). Journal of Pharmacology and Experimental Therapeutics. 305(2). 772–785. 115 indexed citations
8.
Burk, Robert M., David F. Woodward, Achim H.‐P. Krauss, et al.. (2002). Ocular Hypotensive Activity of Prostaglandin F2α (PGF2α) Analogs with Neutral Substituents at Position 1 is Predicted by the Isolated Cat Iris Sphincter Smooth Muscle Preparation but not Ca+ Signalling in Swiss 3T3 Cells. Advances in experimental medicine and biology. 507. 327–330. 1 indexed citations
9.
Schuster, Victor L., Steven W. Andrews, Robert M. Burk, et al.. (2000). Synthetic Modification of Prostaglandin F2αIndicates Different Structural Determinants for Binding to the Prostaglandin F Receptor Versus the Prostaglandin Transporter. Molecular Pharmacology. 58(6). 1511–1516. 24 indexed citations
10.
Krauss, Achim H.‐P., David F. Woodward, Robert M. Burk, et al.. (1997). Pharmacological Evidence for Thromboxane Receptor Heterogeneity—Implications for the Eye. Journal of Ocular Pharmacology and Therapeutics. 13(4). 303–312. 9 indexed citations
11.
Abbas, Farhat, et al.. (1997). A Comparative Study of Thromboxane (TP) Receptor Mimetics and Antagonists on Isolated Human Umbilical Artery and Myometrium. Advances in experimental medicine and biology. 407. 219–230. 4 indexed citations
12.
Krauss, Achim H.‐P., David F. Woodward, Linda L. Gibson, et al.. (1996). Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11‐cyclic carbonate derivatives of prostaglandin F2α. British Journal of Pharmacology. 117(6). 1171–1180. 19 indexed citations
13.
Krauss, Achim H.‐P., David F. Woodward, Linda L. Gibson, et al.. (1995). AGN 191976: A Novel Thromboxane A 2 -Mimetic with Ocular Hypotensive Properties. Journal of Ocular Pharmacology and Therapeutics. 11(3). 203–212. 9 indexed citations
14.
Ponpipom, Mitree M., N. N. Girotra, Robert L. Bugianesi, et al.. (1994). Structure-Activity Relationships of C1 and C6 Side Chains of Zaragozic Acid A Derivatives. Journal of Medicinal Chemistry. 37(23). 4031–4051. 21 indexed citations
15.
Burk, Robert M., et al.. (1994). A mild procedure for etherification of alcohols with primary alkyl halides in the presence of silver triflate. Tetrahedron Letters. 35(44). 8111–8112. 25 indexed citations
16.
Burk, Robert M., Michael E. Garst, Linda L. Gibson, et al.. (1994). Synthesis of a novel series of 3-oxo-2,4-dioxobicyclo[3.2.1]octanes: additional evidence for two thromboxane receptor subtypes.. Bioorganic & Medicinal Chemistry Letters. 4(17). 2103–2106. 2 indexed citations
17.
18.
Burk, Robert M. & Michael B. Roof. (1993). A safe and efficient method for conversion of 1,2- and 1,3-diols to cyclic carbonates utilizing triphosgene. Tetrahedron Letters. 34(3). 395–398. 121 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael E. Garst Breakdown of academic impact, for papers by Takashi Ochiai Breakdown of academic impact, for papers by Gideon Shapiro Breakdown of academic impact, for papers by Alan D. Robertson Breakdown of academic impact, for papers by Pei Xu Breakdown of academic impact, for papers by Andrea Aramini Breakdown of academic impact, for papers by Davide Colavito Breakdown of academic impact, for papers by Larry P. Bausher Breakdown of academic impact, for papers by Henri Cousse Breakdown of academic impact, for papers by John L. Sawyer
Rankless by CCL
2026